|
ATAD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23520000000033E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.823900E-04 |
| Normal-vs-Stage2 |
4.200100E-04 |
| Normal-vs-Stage3 |
3.59119999999713E-05 |
| Normal-vs-Stage4 |
4.21409999999955E-05 |
| Stage1-vs-Stage2 |
3.462800E-01 |
| Stage1-vs-Stage3 |
2.070800E-01 |
| Stage1-vs-Stage4 |
1.269750E-01 |
| Stage2-vs-Stage3 |
9.882200E-01 |
| Stage2-vs-Stage4 |
6.541200E-01 |
| Stage3-vs-Stage4 |
5.891000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98380000004938E-06 |
| Normal-vs-AfricanAmerican |
1.854240E-01 |
| Normal-vs-Asian |
1.643740E-03 |
| Caucasian-vs-AfricanAmerican |
7.857900E-02 |
| Caucasian-vs-Asian |
6.802400E-01 |
| AfricanAmerican-vs-Asian |
2.167800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.59289999996015E-06 |
| Normal-vs-Female |
1.239380E-04 |
| Male-vs-Female |
2.160000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.040800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.39219999997875E-06 |
| Normal-vs-Age(61-80Yrs) |
1.774730E-04 |
| Normal-vs-Age(81-100Yrs) |
2.289600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.496000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.752800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.777000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.907600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.426800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.775800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.172000E-01 |
| Classical-VS-Follicular |
5.341800E-01 |
| Classical-VS-Other |
6.949600E-01 |
| Classical-VS-Normal |
1.846110E-04 |
| Tall-VS-Follicular |
9.811000E-01 |
| Tall-VS-Other |
4.960600E-01 |
| Tall-VS-Normal |
3.420500E-03 |
| Follicular-VS-Other |
6.076600E-01 |
| Follicular-VS-Normal |
1.417820E-03 |
| Other-VS-Normal |
2.815000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.85580000003449E-06 |
| Normal-vs-N1 |
2.417400E-04 |
| N0-vs-N1 |
9.422200E-01 |
|
|
